Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Degenerative Diseases, Central Nervous System

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, A1
Chen, SH1
Kadiiska, MB1
Hong, JS2
Zielonka, J1
Kalyanaraman, B1
Mason, RP1
Gao, HM1
Zhang, F1
Zhou, H1
Kam, W1
Wilson, B1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Degenerative Diseases, Central Nervous System

ArticleYear
Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells.
    Free radical biology & medicine, 2014, Volume: 73

    Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Boronic Acids; Cell Line, Transformed;

2014
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Environmental health perspectives, 2011, Volume: 119, Issue:6

    Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Ani

2011